Loading clinical trials...
Loading clinical trials...
A Multi-center, Observational Study to Describe the Treatment Situation of Chinese County Population With HER2+ & HR+/HER2- Breast Cancer
Conditions
Interventions
pathological stage
Locations
2
China
The First Affiliated Hospital of Xinxiang Medical University
Xinxiang, Henan, China
路平
Xinxiang, Henan, China
Start Date
September 29, 2022
Primary Completion Date
August 1, 2023
Completion Date
September 1, 2024
Last Updated
January 4, 2023
NCT04541381
NCT05468034
NCT03137095
NCT04852887
NCT06393374
NCT07547774
Lead Sponsor
The First Affiliated Hospital of Xinxiang Medical College
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions